Equity · Currency in GBp · Last updated Jun 6, 2026
Diaceutics plc, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics plc was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Looking to balance out your exposure to DXRX.L? The ETFs below have the lowest correlation with DXRX.L — they tend to move on their own, which can help reduce risk when DXRX.L drops. The stock ideas table highlights individual companies that behave independently from DXRX.L.
No Diversifiers Found for DXRX.L
We do not have enough correlation history to rank diversifiers for this symbol yet.
Diversification Analysis
Build a portfolio that complements DXRX.L
Add DXRX.L to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.
